Methods for Quantification of Nucleosome Modifications and Mutations at Genomic Loci and Clinical Applications Thereof
AssigneeEpiCypher, Inc.
InventorsMartis William Cowles, Michael-Christopher Keogh
Life of this patent
Estimating the term…
Loading patent…
AssigneeEpiCypher, Inc.
InventorsMartis William Cowles, Michael-Christopher Keogh
Estimating the term…
The invention relates to clinical applications of quantitative chromatin mapping assays, such as chromatin immunoprecipitation assays and assays using tethered enzymes (e.g., chromatin immunocleavage (ChIC) and cleavage under targets & release using nuclease (CUT&RUN®)). The methods may be used to detect and quantitate the presence of epigenetic modifications and mutations on nucleosomes (histones and/or DNA) from biological samples, monitor changes in the status of modifications and mutations, monitor the effectiveness of epigenetic and mutation therapies, select suitable treatments for a disease, determine the prognosis of a subject, identify biomarkers of a disease, and screen for agents that modify epigenetic or mutation status. The invention further relates to kits for use in the methods of the invention.
1-42. (canceled)
A method for detecting and quantitating the presence of an epigenetic modification or a mutation at an epitope of a core element at a specific genomic locus in chromatin from a biological sample of a subject, the method comprising:
44-55. (canceled)
Dependencies are inferred from the claim text.